Hematology

Caliper Life Sciences’ newly-minted strategy of out-licensing its patent estate to gain greater penetration within the life sciences market gained more steam recently with the late April announcement that lab-on-a-chip giant Affymetrix had agreed to license a portion of the company’s microfluidics technology.

Success of company’s Scaffold-Based Drug Discovery platform puts it on development fast track